Abstract
Ketoconazole (KTZ) functions by suppressing the propagation of ergosterol, an essential element of the fungal cell membrane. However, its conventional topical delivery is often limited by less skin retention due to early drainage and washout. The objective of the present investigation was to fabricate a skin-targeting KTZ-loaded nanostructured lipid carriers (NLCs) with squalene, and thus the localized action.
The NLCs were developed and characterized on various parameters like particle size, PDI, and %EE. The Box-Behnken design (BBD) was employed to effectively fabricate KTZ-loaded NLCs with squalene and Vitamin E TPGS for optimal formulation attributes. In vitro drug release of optimized KTZ NLCs exhibited sustained drug release with 45 ± 5% in 12 h, while ex vivo drug permeation trials on goat skin confirmed improved penetration of drug when contrasted with conventional topical formulation. In vitro drug deposition studies revealed that the gel formulation could impede systemic absorption, offer a greater accumulative uptake of 31.36% after 24 h, and be non-irritant to the skin compared to the conventional formulation.
Further, in vivo studies showed that the optimized gel formulation had significantly improved antifungal effectiveness against Candida albicans. Results suggest that squalene-based NLCs are a promising drug delivery system for KTZ that can improve its skin penetration and therapeutic efficacy.
Read more here
Singh, R.P., Narang, R.K., Sharma, N. et al. Novel Squalene Based Nanostructured Lipid Carriers of Ketoconazole for Enhanced Skin Penetration and Better Anti-Fungal Control: An In-Vitro, Ex-Vivo and In-Vivo Evaluation. BioNanoSci. 15, 490 (2025). https://doi.org/10.1007/s12668-025-02114-y
Visit our free webinar:
The Right Choice:
Direct Compression Lactose in Drug Development & Sustainability











































All4Nutra








